These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8652366)

  • 21. Use of bisphosphonates in patients with metastatic bone disease.
    Berenson JR; Lipton A
    Oncology (Williston Park); 1998 Nov; 12(11):1573-9; discussion 1579-81. PubMed ID: 9834935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aredia: the once-monthly infusion for the treatment of bone metastases.
    Lipton A
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S1-5. PubMed ID: 9801852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Progress in diagnosis and therapy: Hypercalcemia due to multiple myeloma and wide-spread neoplastic bone metastasis].
    Abe M
    Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):675-80. PubMed ID: 17506303
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
    Paterson AH; Kanis JA; Powles TJ; McCloskey E; Hanson J; Ashley S
    Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of bisphosphonates in patients with breast cancer.
    Van Poznak CH
    Cancer Control; 2002; 9(6):480-9. PubMed ID: 12514566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of bisphosphonates in skeletal metastasis.
    Elomaa I
    Acta Oncol; 2000; 39(4):445-54. PubMed ID: 11041106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bone metastases in breast carcinoma. Bisphosphonate protects from complications].
    MMW Fortschr Med; 2004 Apr; 146(14):45. PubMed ID: 15344758
    [No Abstract]   [Full Text] [Related]  

  • 28. Aetiology of bone disease and the role of bisphosphonates in multiple myeloma.
    Ashcroft AJ; Davies FE; Morgan GJ
    Lancet Oncol; 2003 May; 4(5):284-92. PubMed ID: 12732166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic bone disease and tumour-induced hypercalcaemia: the role of bisphosphonates.
    Heatley S
    Int J Palliat Nurs; 2001 Jun; 7(6):301-2, 304-7. PubMed ID: 12066026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of bisphosphonates in orthopedic surgery: pearls and pitfalls.
    Lozano-Calderon SA; Colman MW; Raskin KA; Hornicek FJ; Gebhardt M
    Orthop Clin North Am; 2014 Jul; 45(3):403-16. PubMed ID: 24975766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone complications in multiple myeloma.
    Berenson JR; Rajdev L; Broder M
    Cancer Biol Ther; 2006 Sep; 5(9):1082-5. PubMed ID: 16969119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I; Kousidou OCh; Karamanos NK
    In Vivo; 2005; 19(1):311-8. PubMed ID: 15796191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Practice guidelines of the use of bisphosphonates in solid tumours with bone metastases and in multiple myeloma].
    Brantus JF; Roemer-Becuwe C; Cony-Makhoul P; Salino S; Fontana A; Debourdeau P; Thomas T; Guastalla JP; Ghesquieres H; Sebban C; Pavic M; Collet P; Larbre JP; Martinon S; Brocard F; Bodard AG; Blanc G; Balestrière V; Favier B; Farsi F; Krakowski I; Biron P;
    Rev Med Interne; 2011 Aug; 32(8):494-505. PubMed ID: 21376431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multiple myeloma].
    Abe M
    Nihon Rinsho; 2009 May; 67(5):991-5. PubMed ID: 19432122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ibandronate: its pharmacology and clinical efficacy in the management of tumor-induced hypercalcemia and metastatic bone disease.
    Heidenreich A; Ohlmann CH
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):991-1005. PubMed ID: 15606328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
    Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
    J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of bisphosphonates in multiple myeloma.
    Kyle RA
    Ann Intern Med; 2000 May; 132(9):734-6. PubMed ID: 10787368
    [No Abstract]   [Full Text] [Related]  

  • 38. Denosumab versus intravenous bisphosphonate use for hypercalcemia in multiple myeloma.
    Lei MM; Tavares E; Buzgo E; Lou U; Raje N; Yee AJ
    Leuk Lymphoma; 2022 Dec; 63(13):3249-3252. PubMed ID: 36036363
    [No Abstract]   [Full Text] [Related]  

  • 39. Bisphosphonates in breast cancer patients with skeletal metastases.
    Shapiro CL
    Hematol Oncol Clin North Am; 1994 Feb; 8(1):153-63. PubMed ID: 8150777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bisphosphonates in the treatment concept of metastatic breast carcinoma].
    Possinger K; Flath B; Akrivakis K
    Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):M91-4. PubMed ID: 8964444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.